Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.57 |
| ▸ | MGAM | O43451 | 1/20 | 0.54 |
| ▸ | MAOA | P21397 | 2/20 | 0.53 |
| ▸ | MAOB | P27338 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.44 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4779879 | 1.00 | PTGS1 (0.57) | PTGS1MGAMMAOAMAOBCYP3A4 | |
| SCHEMBL25824259 | 1.00 | PTGS1 (0.57) | PTGS1MGAMMAOAMAOBCYP3A4 | |
| SCHEMBL29618998 | 1.00 | PTGS1 (0.57) | PTGS1MGAMMAOAMAOBCYP3A4 | |
| SCHEMBL29682883 | 1.00 | PTGS1 (0.57) | PTGS1MGAMMAOAMAOBCYP3A4 | |
| SCHEMBL29480609 | 1.00 | PTGS1 (0.57) | PTGS1MGAMMAOAMAOBCYP3A4 | |
| SCHEMBL29618999 | 1.00 | PTGS1 (0.57) | PTGS1MGAMMAOAMAOBCYP3A4 | |
| SCHEMBL29480585 | 0.87 | MAPT (0.60) | PTGS1MGAMMAOAMAOBCYP3A4 | |
| SCHEMBL30554025 | 0.85 | PTGS1 (0.55) | PTGS1MAOAMAOBCYP3A4MAPT | |
| SCHEMBL21168205 | 0.80 | MAOA (0.64) | PTGS1MGAMMAOAMAOBCYP3A4 | |
| SCHEMBL31237248 | 0.80 | MAOA (0.64) | PTGS1MGAMMAOAMAOBCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122005744-A | Quality marker for preventing and treating kidney-yang deficiency by using medicinal and edible formula composition, and preparation method and application thereof | 广西壮族自治区中医药研究院 | 2026-05-12 | — | — | CN | claimed |
| CN-116106462-A | Fingerprint of Qilong Zhuang Er oral liquid and application of Qilong Zhuang Er oral liquid in quality control | 西安正大制药有限公司 | 2023-05-12 | — | — | CN | claimed |
| CN-122005744-A | Quality marker for preventing and treating kidney-yang deficiency by using medicinal and edible formula composition, and preparation method and application thereof | 广西壮族自治区中医药研究院 | 2026-05-12 | — | — | CN | disclosed |
| US-12507703-B2 | Methods, devices and compositions for preserving human milk | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-12-30 | — | — | US | disclosed |
| US-20250250647-A1 | STABLE CELL CLONES HARBORING REPLICATING SARS-COV-2 RNA | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN (US) | 2025-08-07 | — | — | US | disclosed |
| US-20250169516-A1 | METHODS, DEVICES AND COMPOSITIONS FOR PRESERVING HUMAN MILK | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-05-29 | — | — | US | disclosed |
| US-12239142-B2 | Methods, devices and compositions for preserving human milk | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-03-04 | — | — | US | disclosed |
| CN-118866261-A | Latent medicine for treating amyotrophic lateral sclerosis and research and development method | 陕西省中医医院 | 2024-10-29 | — | — | CN | disclosed |
| CN-118593676-A | A Chinese medicinal composition for preventing or treating alopecia | 天津中医药大学第一附属医院 | 2024-09-06 | — | — | CN | disclosed |
| CN-118576581-A | Application of pterocarpan compounds and pharmaceutical composition | 澳门科技大学 | 2024-09-03 | — | — | CN | disclosed |
| CN-118525837-A | Application of micro-nano bubble ozone water in postharvest storage of fresh astragalus | 甘肃农业大学 | 2024-08-23 | — | — | CN | disclosed |
| CN-114748490-B | Pharmaceutical composition for treating premature ovarian failure, application and preparation method thereof | 南方科技大学 | 2023-12-12 | — | — | CN | disclosed |
| CN-116898933-A | Traditional Chinese medicine composition for treating ulcerative colitis and preparation method thereof | 吉林农业科技学院 | 2023-10-20 | — | — | CN | disclosed |
| CN-115078561-B | Separation method of chemical components in astragalus membranaceus and application thereof | 天津中医药大学 | 2023-08-29 | — | — | CN | disclosed |
| CN-116135216-A | Traditional Chinese medicine composition for treating cervical abscess type lymph node tuberculosis | 首都医科大学附属北京胸科医院 | 2023-05-19 | — | — | CN | disclosed |
| CN-116106462-A | Fingerprint of Qilong Zhuang Er oral liquid and application of Qilong Zhuang Er oral liquid in quality control | 西安正大制药有限公司 | 2023-05-12 | — | — | CN | disclosed |
| WO-2023080157-A1 | THERAPEUTIC OR PROPHYLACTIC FOR HTLV-1-ASSOCIATED MYELOPATHY (HAM), THERAPEUTIC EFFICACY DETERMINATION METHOD, AND ACTIVITY EVALUATION METHOD OR DIAGNOSIS METHOD | 国立大学法人東京大学 | 2023-05-11 | — | — | WO | disclosed |
| CN-115990177-A | Application of astragalus root pterocarpan glycoside in preparing medicament for treating kidney disease | 澳门科技大学 | 2023-04-21 | — | — | CN | disclosed |
| CN-115078561-A | Method for separating chemical components from astragalus membranaceus and application of method | 天津中医药大学 | 2022-09-20 | — | — | CN | disclosed |
| CN-113917031-B | Method for determining blood concentration of lung-tonifying and blood-activating capsule in vivo by UHPLC-MS/MS method | 广东雷允上药业有限公司 | 2022-06-07 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12507703-B2 | Methods, devices and compositions for preserving human milk | LPL, CEL, LPO | PTGS1 4638/4885MGAM 92/4885MAOA 471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.